Erythromycin B Oxime | CAS 53274-43-4 - Solicitar cotización

Erythromycin B Oxime is chemically (3R,4S,5S,6R,7R,9R,11S,12R,13R,14R)-6-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-14-ethyl-7,12-dihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-10-(hydroxyimino)-3,5,7,9,11,13-hexamethyloxacyclotetradecan-2-one. It is also known as 12-Deoxyerythromycin 9-Oxime. Erythromycin B Oxime is supplied with detailed characterization data compliant with regulatory guideline. Erythromycin B Oxime can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Erythromycin.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.